Sunitinib Induced Diffuse Alveolar Hemorrhage: A Case Report

Supreet Sethi, Nutan Bhaskar


A 68-year-old man with papillary renal cell carcinoma of the transplanted kidney presented with worsening respiratory distress while on treatment with sunitinib. Computerized tomography of chest revealed diffuse ground-glass opacities, and sequentially bloody bronchoalveolar lavage fluid was noted on bronchoscopy. There was marked clinico-radiologic improvement after withdrawal of sunitinib. This is the first case report of diffuse alveolar hemorrhage as an adverse effect of sunitinib in non-metastatic papillary renal cell carcinoma. With the increasing use of sunitinib in treatment of solid tumors, it is important to be aware of this potential adverse effect. Clinicians need to be vigilant for alveolar hemorrhage in patients on sunitinib with or without evidence of lung metastasis.

J Med Cases. 2013;4(3):196-198


Diffuse Alveolar Hemorrhage; Tyrosine kinase inhibitor; Renal cell carcinoma; Respiratory failure

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website:   editorial contact:
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.